Aaron M. Lambert, Ph.D. Email & Phone Number

Cambridge, Ma, Us

London, England, United Kingdom; New York, New York; Chicago, Illinois

Principal Medical Writer/Consultant for Virgo Health, improving medical and scientific communications for several multinational pharmaceutical & biotechnology companies, with a primary role as the lead medical writer in scientific platform development for AstraZeneca's next-generation COVID-19 prophylactic spike-protein–targeting monoclonal antibodies (mAbs) for better protecting immunocompromised individuals. This work will aid in AstraZeneca publishing and disseminating their findings from experiments and clinical trials on the epidemiology, unmet need, mechanism of action, efficacy, and safety of these next-generation COVID-19 mAbs. Since immunocompromised individuals represent only 3% of the US population yet suffer from nearly 50% of all COVID-19–related hospitalizations and deaths due to their immune systems being unable to marshal a sufficient defense from either COVID-19 vaccines or infections, providing them with an exogenous-derived next-generation mAb defense that is carefully designed to combat and concomitantly best evade resistance and variant mechanisms of COVID-19 will likely save and substantially improve many lives. While our headquarters are in London, I continue to work remotely in Boston/Cambridge (MA), primarily working with our New York–based team and coordinating across teams in London and Chicago as needed. And although I've previously been offered positions as a Medical Director and/or Scientific Director to lead a team of medical writers, I prefer to avoid managerial obligations and instead focus on diving deep into the scientific and medical literature firsthand for creating deliverables; with this impetus as a Principal Medical Writer, I am now able to earn as much as or more than I would in most roles as a Medical/Scientific Director. This current role is separate from my ongoing role as a Scientific Editor/Consultant for multiple other companies around the world focused on scientific communications for academic labs.

Knutsford, London, Oxford, Cambridge, Brighton (England, Uk); New York, Ny; San Diego, Ca

Senior Medical Writer/Consultant for Prime Global, improving medical and scientific communications for several multinational pharmaceutical & biotechnology companies, with a primary role as the lead medical writer in scientific platform development for Blueprint Medicines (based in the Harvard/MIT/biotech hub of Cambridge, MA) to aid in them publishing their findings from experiments and clinical trials on the epidemiology, unmet need, mechanism of action, efficacy, and safety for each of several precision therapies for treating various cancers. While our headquarters are in the United Kingdom, I'm primarily working with our New England–based team (directly reporting to a medical director in the Yale/biotech hub of New Haven, CT) and coordinating across teams in New York City, San Francisco, San Diego, and several teams throughout the UK (London, Cambridge, Oxford, Brighton, Knutsford). This role is separate from my ongoing role as a Scientific Editor/Consultant for multiple other companies around the world focused on scientific communications for academic labs.

New York, New York

Senior Medical Editor/Consultant for BGB Group, improving medical and scientific communications for 20+ multinational pharmaceutical & biotechnology companies—including Pfizer, Merck, Bristol Myers Squibb, Amgen, Biogen, GlaxoSmithKline, Genzyme, and Eisai—as well as various startup and mid-stage biotechnology companies. This role is separate from my ongoing role as a Scientific Editor/Consultant for multiple other companies around the world (e.g., Accdon) focused on scientific communications for academic labs.

Greater Boston, Massachusetts; Shanghai, China; Cork, Ireland; Rio De Janeiro, Brazil

Scientific Editor/Consultant for Accdon and several other companies around the world, improving scientific communications for academic labs; in this role, I've helped hundreds of labs to improve the motivation, background, experimental design, statistical analyses, interpretations/implications of findings, and the overall communication and presentation of these components for 1,000+ manuscripts (across all domains of biology), many of which have since been published in high-profile journals such as Nature, Science, Cell, and The Lancet. This role is separate from my concurrent role as a Senior Medical Editor/Consultant for BGB Group, focused on improving medical and scientific communications for several multinational pharmaceutical & biotechnology companies.

Cambridge, Massachusetts

Engert LabHarvard Biological LaboratoriesCenter for Brain ScienceDepartment of Molecular and Cellular BiologyModel System: Zebrafish

Minneapolis, Minnesota

Masino LabJackson HallGraduate Program in NeuroscienceDepartment of NeuroscienceModel System: Zebrafish

Chicago, Illinois

Dubocovich LabMcGaw Medical CenterFeinberg School of MedicineDepartment of Molecular Pharmacology and Biological ChemistryModel Systems: Cell Culture, Mouse, Rhesus Monkey

Chicago, Illinois

Mason LabSurgery Brain Research InstitutePritzker School of MedicineDepartment of Neurobiology, Pharmacology, and PhysiologyModel System: Rat

Urbana-Champaign, Illinois

Wickesberg LabPsychology BuildingDivision of Biological PsychologyDepartment of PsychologyModel System: ChinchillaKorol/Gold LabPsychology BuildingDivision of Biological PsychologyDepartment of PsychologyModel System: RatGratton/Fabiani LabBeckman Institute for Advanced Science and TechnologyDivision of Cognitive NeuroscienceDepartment of PsychologyModel System: Human

Postdoctoral Training, Neuroscience

Center for Brain Science Department of Molecular and Cellular Biology

Doctor Of Philosophy (Ph.D.), Neuroscience, 3.96 Gpa Over 104 Semester Hours

Graduate Program in Neuroscience Department of Neuroscience

Bachelor Of Science (B.S.), Biological Psychology, 3.80 Gpa Over 152 Semester Hours

Division of Biological Psychology Department of Psychology